BIMB privatisation was based on The Star article only. If BIMB wants to backdoor list Bank Islam, then it need to merge with smaller banks like MBSB first, Bank Islam too small for listing. And also it needs to privatise STMB first to become it's subsidiary. And another factor worsening loan growth, how to list if banks are suffering?

BIMB drop because of ex date on 28th for dividend entitlement.. market price readjustment only

It was Lembaga Tabung Haji who dumped warrant for the last 2 trading days. They getting rid of their free warrant in exchange for mother share

Huhuhuhu...I want to go to Genting and jump down

Singapore-based TauRx will update on Phase III studies of its tau aggregation inhibitor in a podium presentation at the Alzheimer’s Association International Conference (AAIC) in Toronto on July 27, providing an initial glimpse of decades of effort that cost more than $300 million.

Claude Wischik, co-founder and executive chairman of TauRx, has worked on a candidate to inhibit the progression of the tau tangle pathology originally discovered by Alois Alzheimer for about three decades. The company has been around for nearly 15 years, raising money from doctors in Singapore and Malaysia as well as funds from Singapore's Temasek and Malaysian casino and resort operator Genting.

His work is at variance with a focus on beta amyloid that firms such as Eli Lilly ($LLY) and Pfizer ($PFE) have explored aggressively. His research suggests one way to treat the symptoms is by dissolving paired helical filaments with pharmaceutically viable compounds acting as TAIs in order to delay disease onset.

Phase II trials were said to show support for the tau hypothesis as a leading cause of Alzheimer's disease and suggested a treatment that targets tau aggregation could possibly slow disease progression in mild to moderate Alzheimer’s.

"TauRx is now confirming these findings in Phase III clinical trials with the company's second-generation TAI (tau aggregation inhibitor), LMTX," the company said on its website.

"The Phase III clinical trial program involves over 1,900 patients and comprises three separate trials: two in Alzheimer's disease and one in the rare neurodegenerative disorder, behavioral variant frontotemporal dementia. This Phase II program is now coming to a conclusion."

This week, TauRx will make what it termed an "an initial announcement of the results of the first two trials to complete" at two presentations at AAIC.

At stake is entry into a market that GBI Research estimates could reach $11.3 billion by 2021 across 8 major countries, including the U.S. and Japan.

Today TauRx good news will be announced..success of trial 1 and 2 of Phase 3...tomorrow limit up meleTOPPPP

Only 2 days to good news TauRx..meleTOPPPPP

Wednesday good news coming...meleTOPP

Hehehehe...sell to me now..6 days from now good news from TauRx..you buy from me 10.00

On 27th, Genting will limit up..good news from TauRx

Wakakaka. Apa lu cerita friend? Mabuk cow dung ah? In 2 years TauRx already manufacture LMTX for Alzheimer larr...now waiting good news on 27th only

Posted by staind86 > Jul 19, 2016 06:29 AM | Report Abuse

Go check their official website. under clinical trial and read until last 2 sentences. then, you know apa wa cerita.

Phase 3 clinical trials are currently underway with TauRx’s second-generation tau aggregation inhibitor, LMTX®. The Phase 3 programme comprises two clinical trials in Alzheimer’s disease and a further trial in the neurodegenerative orphan indication behavioural variant frontotemporal dementia.

The trials are fully recruited and results are expected in Q3 2016.

Phase 3 started in 2012...finish trial and collected data 2015..apa lu cerita?

Wakakaka. Friend, which planet are you from? 27th announce Phase 3 larr..so sohigh larr you

9 days to good news...by then already 10.00

Hehehe..if you doubt, dun buy, sell. But you miss if good news come 27th. MeleTOPPP

Haiyoh. Next year TauRx already listed in Nasdaq, cure launch to mass market. Genting probably 20.00. meleTOPP

Posted by staind86 > Jul 14, 2016 06:23 PM | Report Abuse

Ah, I was just speculating the 3rd trial presentation at the conference. The article sounds like it is the case.

You very outdated friend. Phase 3 already completed, result announce on 27th. By then Genting sudah 12.00..meleTOOPP


Posted by yyloh21 > Jul 14, 2016 05:00 PM | Report Abuse

The coming conf is only announcing the first 2 trials results. Still there is phase 3. Therefore, beware when you rush in to buy.

14 days to go before TauRx good news..meleTOPP

Hehehe...19 days to TauRx good news

Hehehe...whatever if you dun buy..later we laugh at you..tapao Genting if not regret later

Hehehe...already plan for nasdaq listing...still tidur ka kawan2...tapao Genting

Hehehehe...hello kawan, if cannot pass phase 2 can bungkus..Taurx completed phase 3..wait for good news on 27 July..2017 nasdaq listing

Less than 4 weeks, 27 July good news for TauRx, final phase 3 completed and presented. Tapao Genting early before it go up. http://labiotech.eu/alzheimers-tau-inhibitor-aberdeen-taurx/

90% success rate. Wait for official announcement on 27 July

Wait for good news on 27 July, TauRx here we come

“In total we have 1,910 patients enrolled so far in clinical trials being conducted in more than 200 clinics around the world in 20 countries. If all goes well, 2017 could be when we see this drug in the pharmacies and on the street.”

Apa lagi, TauRx announcement this July. http://www.bloomberg.com/news/articles/2016-06-27/after-190-tries-are-we-any-closer-to-a-cure-for-alzheimer-s
http://www.themonitordaily.com/alzheimer-cure-targets-tau-protein/211942/

I heard phase 3 of TauRx result is positive...wait for announcement next month